Related Experiment Video
Updated: Mar 30, 2026

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
Published on: May 21, 2019
Fluid resuscitation in Ebola Virus Disease: A comparison of peripheral and central venous accesses
Jean Cotte1, Pierre-Yves Cordier2, Julien Bordes1
1Anaesthesiology and Critical Care, Sainte-Anne Military Teaching Hospital, 83800 Toulon, France; Healthcare Workers Ebola Treatment Unit, Conakry, Guinea.
Introduction:
Ebola Virus Disease (EVD) causes severe diarrhoea and vomiting, leading to dehydration and electrolyte abnormalities. Treatment remains supportive and often requires intravenous (IV) access. IV catheters are difficult to insert and maintain in this context. Our primary objective was to compare peripheral venous catheters (PVCs) and central venous catheters (CVCs) for volume resuscitation in patients with EVD.
Material And Methods:
We performed a prospective observational study between January and March 2015 at the Conakry Healthcare Workers Ebola Treatment Unit (ETU). The primary judgement criterion was the ratio of the daily infused volume of fluids to the prescribed volume (DIV/PV).
Results:
Fourteen patients were admitted. Twenty-eight PVCs and 8 CVCs were inserted. CVCs had a longer survival time (96 ± 34 hours versus 33.5 ± 21 hours, P<0.001). The mean DIV/PV was higher for the CVCs (0.95±0.08 versus 0.7 ± 0.27, P<0.001), as well as the number of days with full administration of prescribed IV fluids (71.2% versus 34.1%, P=0.002).
Discussion:
Inserting CVCs is a safe and reliable way of obtaining IV access in ETUs, provided adequately trained personnel are available. CVCs optimize fluid infusion compared to PVCs. Further studies comparing fluid management strategies in EVD are necessary.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Acute Respiratory Failure-IV

